Sharechat Logo

Intervention has not worked so what next?

-Press Release

Tuesday 12th June 2007

Text too small?
The Canterbury Manufacturers Association (CMA) says that the Reserve Banks intervention in the currency markets is an admission that we need more and better medicine to cure domestic inflation without the exchange rate side effect associated with the OCR.

In a global economy we simply cannot sustain policy settings that carry such dire consequences for exporters and do little to influence the real target, domestic inflation, says Chief Executive John Walley.

The OCR has a limited impact of giving the domestic economy a cold, how long can we depend on that approach when it is clear for anyone to see that the export sector in the latter stages of terminal pneumonia.

We need better alternatives, we need supplementary measures.

We cant expect a single intervention to make a lasting difference, but yesterdays move is finally an admission that supplementary measures are necessary and must be available.

On the idea of intervention, if the rest of the world is happy to buy our paper, maybe we should keep printing our money?

The RBNZs action is recognition that monetary policy currently has some significant limitations.

The problems around an overvalued dollar are more visible than the response of domestic inflationary pressure; the side effects are drowning any desired outcomes. The question is what happens next.

If the RBNZ takes, as with the OCR, a low-key approach then the impact will be diluted instead of a clear, strong and consistent message to the markets, says Walley.

Theory has it that interventions do not work for long, so other medicines are necessary to deal with domestic inflation without the exchange rate side effect.

This requires action on the part of the Government and not just the RBNZ. Yesterdays move may have sent the right message, but what happened shows that such messages need to be delivered stronger and longer.

  General Finance Advertising    

Comments from our readers

No comments yet

Add your comment:
Your name:
Your email:
Not displayed to the public
Comment:
Comments to Sharechat go through an approval process. Comments which are defamatory, abusive or in some way deemed inappropriate will not be approved. It is allowable to use some form of non-de-plume for your name, however we recommend real email addresses are used. Comments from free email addresses such as Gmail, Yahoo, Hotmail, etc may not be approved.

Related News:

December 27th Morning Report
FBU - Fletcher Building Announces Director Appointment
December 23rd Morning Report
MWE - Suspension of Trading and Delisting
EBOS welcomes finalisation of First PWA
CVT - AMENDED: Bank covenant waiver and trading update
Gentrack Annual Report 2024
December 20th Morning Report
Rua Bioscience announces launch of new products in the UK
TEM - Appointment to the Board of Directors